About
-
Headquarters
Chennai, Tamil Nadu
-
Since
2015
Adiuvo Diagnostics, a technology-oriented social enterprise, specializes in developing state-of-the-art platform technologies in Optoelectronics, aimi Read moreng primarily to enhance early disease detection in resource-limited settings. The company has designed an advanced imaging tool capable of capturing multispectral autofluorescence images. By employing machine learning algorithms on these images, the technology delivers swift, label-free diagnostic solutions with broad applications, spanning from identifying pathogens to evaluating skin conditions and diagnosing cancer. This innovative approach significantly contributes to advancing healthcare in settings with limited resources. Adiuvo Diagnostics offers precise and advanced diagnostic devices tailored specifically for healthcare professionals working in low-resource environments. Their product range includes skinscope AD, a non-invasive tool for screening skin and soft tissue infections, a modular reader for visualizing and measuring molecular diagnostic tests, and an MTB screening device for detecting Mycobacterium tuberculosis. Operating in the B2B sector within HealthTech markets, the company's flagship product, Illuminate, is a wound infection screening device utilizing artificial intelligence for accurate, contactless identification of gram-type bacteria.
Cause Area
Sector
Sub Sector
Programs
-
Illuminate
Illuminate stands out as the pioneering Artificial Intelligence Enabled Comprehensive Wound Infection Assessment and Monitoring Device. Featuring a revolutionary "OPTICAL BIOPSY" solution, it delivers label-free, non-contact Gram Type Bacterial Recognition in under 2 minutes. The device ensures real-time pathogen detection, providing insights into wound bioburden exceeding 10^4 CFU/g of tissue. Illuminate goes beyond by offering comprehensive wound reporting with a spatially overlaid bioburden map, precise gram-type classification, and a web dashboard for intuitive wound tracking. Its AI capabilities enable smarter predictions and continuous learning, ensuring ongoing model improvement for enhanced accuracy in monitoring and assessing wound healing progress.
-
Publications
Initiating a noteworthy initiative, numerous peer-reviewed publications showcase the impact of a real-time fluorescence imaging device developed for guiding antibiotic treatment in superficial skin infections. These publications underscore the utility and effectiveness of the device, presenting evidence through studies such as the rapid handheld screening for skin and soft tissue infections, assessment of pathogens using autofluorescence lifetime characteristics, and the clinical significance of the imaging device in evaluating wound infections. The publications delve into innovative approaches like Artificial Intelligence methodologies applied to diabetic foot care technologies, providing a comprehensive narrative review and highlighting the state-of-the-art in point-of-care optical devices for clinical imaging and screening.
Leadership Team
Demographics & Structure
-
No. of Employees
21-50
M&E
-
Internal, External Assessors
No
Policies
-
Ethics and Transparency Policies
No
-
Formal CEO Oversight & Compensation Policy
No
Political & Religious Declarations
-
On Affiliation if any
No
-
On Deployment Bias if any
No
Registration Details
-
Registration ID
U74120AP2015PTC097966
-
FCRA
Not Available
-
CSR Registration Number
Not Available
Location
-
Headquarters
Unit 18 and 19, Golden Jubilee Biopark, 4th Main Rd, 2nd Cross St ,SIPCOT IT Park, Siruseri, Chennai, 603103
Directions
Other Details
-
Type & Sub Type
For-profit
Private Limited Company